MeSH term
Frequency | Condition_Probility | Animals | 33 | 0.0 |
CDK9 Protein Kinase | 57 | 85.0 |
Cell Nucleus/*metabolism | 3 | 0.0 |
Cercopithecus aethiops | 3 | 0.0 |
Cyclin-Dependent Kinases/*metabolism | 13 | 4.0 |
Humans | 96 | 0.0 |
Mice | 19 | 0.0 |
Research Support, Non-U.S. Gov't | 68 | 0.0 |
Amino Acid Sequence | 17 | 0.0 |
*CDC2-CDC28 Kinases | 2 | 0.0 |
Cyclin-Dependent Kinases/*physiology | 7 | 14.0 |
Gene Products, tat/chemistry/*physiology | 2 | 50.0 |
HIV-1/*genetics | 14 | 4.0 |
Hela Cells | 42 | 0.0 |
Molecular Sequence Data | 23 | 0.0 |
Phosphorylation | 25 | 0.0 |
*Promoter Regions (Genetics) | 6 | 0.0 |
RNA Polymerase II/*chemistry | 2 | 40.0 |
Repetitive Sequences, Amino Acid | 2 | 1.0 |
Research Support, U.S. Gov't, P.H.S. | 77 | 0.0 |
*Transcription, Genetic | 20 | 1.0 |
Cloning, Molecular | 4 | 0.0 |
Cyclin-Dependent Kinases/genetics/*metabolism | 8 | 12.0 |
Enhancer Elements (Genetics) | 2 | 0.0 |
Genes, Reporter | 3 | 0.0 |
Nuclear Proteins/metabolism | 2 | 0.0 |
Positive Transcriptional Elongation Factor B | 34 | 57.0 |
Promoter Regions (Genetics) | 12 | 0.0 |
Protein-Serine-Threonine Kinases/genetics/*metabolism | 5 | 2.0 |
Recombinant Fusion Proteins/genetics/metabolism | 11 | 1.0 |
*Repressor Proteins | 3 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 2 | 0.0 |
Base Sequence | 9 | 0.0 |
*Chromosomal Proteins, Non-Histone | 3 | 1.0 |
Dichlororibofuranosylbenzimidazole/pharmacology | 5 | 18.0 |
Enzyme Inhibitors/pharmacology | 4 | 0.0 |
Gene Products, tat/*genetics/metabolism | 2 | 14.0 |
HIV-1/*genetics/metabolism | 2 | 7.0 |
RNA Polymerase II/genetics/*metabolism | 2 | 16.0 |
Transcription Factors/genetics/metabolism | 4 | 0.0 |
Transcription, Genetic | 24 | 0.0 |
*Transcriptional Elongation Factors | 3 | 10.0 |
*Cell Cycle Proteins | 2 | 0.0 |
Cell Line | 15 | 0.0 |
Gene Products, tat/*metabolism | 14 | 14.0 |
HIV Long Terminal Repeat/genetics | 4 | 8.0 |
Plasmids | 2 | 0.0 |
Protein Kinases/*metabolism | 2 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 12 | 1.0 |
RNA Polymerase II/chemistry/*metabolism | 6 | 31.0 |
Cyclins/*metabolism | 14 | 5.0 |
DNA Primers | 2 | 0.0 |
Jurkat Cells | 7 | 0.0 |
Protein Binding | 17 | 0.0 |
Blotting, Western | 10 | 0.0 |
Cell Differentiation/physiology | 2 | 0.0 |
Cyclins/*physiology | 2 | 3.0 |
Cycloheximide/pharmacology | 2 | 0.0 |
Precipitin Tests | 7 | 0.0 |
Protein Synthesis Inhibitors/pharmacology | 2 | 0.0 |
Transcription, Genetic/*physiology | 2 | 1.0 |
Serine/metabolism | 3 | 0.0 |
*Gene Expression Regulation, Viral | 3 | 1.0 |
HIV-1/genetics/*physiology | 3 | 2.0 |
*Virus Replication | 5 | 1.0 |
Gene Expression Regulation, Viral | 7 | 2.0 |
*HIV Long Terminal Repeat | 7 | 7.0 |
*Trans-Activation (Genetics) | 7 | 0.0 |
Antineoplastic Agents/*pharmacology | 2 | 0.0 |
Cell Cycle/drug effects | 4 | 0.0 |
Cyclin-Dependent Kinases/*antagonists & inhibitors | 4 | 2.0 |
Cyclins/physiology | 3 | 7.0 |
Cyclin-Dependent Kinases/metabolism | 15 | 4.0 |
Cyclins/metabolism | 12 | 2.0 |
Gene Products, tat/genetics/*metabolism | 6 | 14.0 |
Nucleic Acid Conformation | 3 | 0.0 |
Protein Structure, Tertiary | 13 | 0.0 |
Binding Sites | 6 | 0.0 |
Models, Biological | 6 | 0.0 |
Mutation | 3 | 0.0 |
Plasmids/metabolism | 4 | 0.0 |
RNA Polymerase II/metabolism | 15 | 13.0 |
Recombinant Fusion Proteins/metabolism | 5 | 0.0 |
Recombinant Proteins/metabolism | 4 | 0.0 |
Time Factors | 6 | 0.0 |
Macromolecular Substances | 5 | 0.0 |
Models, Genetic | 5 | 0.0 |
NF-kappa B/metabolism | 2 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 8 | 0.0 |
COS Cells | 7 | 0.0 |
Cyclins/genetics/metabolism | 2 | 3.0 |
*Gene Expression Regulation | 7 | 0.0 |
Gene Products, tat/metabolism | 6 | 16.0 |
Cells, Cultured | 11 | 0.0 |
Transfection | 14 | 0.0 |
RNA, Small Nuclear/*metabolism | 2 | 28.0 |
Glutathione Transferase/metabolism | 5 | 0.0 |
HIV-1/*metabolism | 4 | 1.0 |
Protein-Serine-Threonine Kinases/genetics/metabolism | 2 | 1.0 |
Trans-Activation (Genetics) | 14 | 0.0 |
Transcription Factors/metabolism | 2 | 0.0 |
Cell Cycle/physiology | 2 | 0.0 |
Proteasome Endopeptidase Complex | 3 | 0.0 |
S-Phase Kinase-Associated Proteins | 2 | 2.0 |
Transcription, Genetic/physiology | 2 | 1.0 |
Cyclins/*biosynthesis | 2 | 3.0 |
Lymphocyte Activation | 2 | 0.0 |
Protein Subunits | 2 | 0.0 |
RNA Polymerase II/chemistry/metabolism | 2 | 25.0 |
HIV-1/*genetics/*metabolism | 3 | 20.0 |
RNA/metabolism | 2 | 0.0 |
Transcription Factors/*metabolism | 4 | 0.0 |
*Transcription Factors, TFII | 3 | 2.0 |
HIV Long Terminal Repeat | 10 | 7.0 |
Proviruses/genetics | 2 | 3.0 |
Cell Differentiation | 6 | 0.0 |
Gene Products, tat/physiology | 3 | 17.0 |
Gene Expression | 4 | 0.0 |
*Genes, MHC Class II | 2 | 0.0 |
Nuclear Proteins/genetics/*metabolism | 2 | 0.0 |
Trans-Activators/genetics/*metabolism | 2 | 0.0 |
Female | 3 | 0.0 |
Transcription, Genetic/drug effects/genetics | 2 | 8.0 |
Substrate Specificity | 5 | 0.0 |
Apoptosis | 3 | 0.0 |
CDK9 Protein Kinase/*metabolism | 2 | 100.0 |
Enzyme Activation | 5 | 0.0 |
Rats | 2 | 0.0 |
Cell Line, Tumor | 4 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Nuclear Proteins/*metabolism | 2 | 0.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
Trans-Activators/*metabolism | 2 | 0.0 |
Transcription, Genetic/genetics | 2 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 3 | 0.0 |
U937 Cells | 2 | 0.0 |
CDK9 Protein Kinase/genetics/*metabolism | 2 | 100.0 |
Cyclins/genetics/*metabolism | 7 | 8.0 |
Positive Transcriptional Elongation Factor B/metabolism | 3 | 100.0 |
RNA, Small Nuclear/metabolism | 2 | 20.0 |
Comparative Study | 2 | 0.0 |
Adenosine Triphosphate/metabolism | 4 | 0.0 |
Cyclin-Dependent Kinases/chemistry/genetics/*metabolism | 2 | 50.0 |
Mutagenesis | 4 | 0.0 |
Peptides/metabolism | 2 | 0.0 |
RNA Polymerase II/*metabolism | 4 | 4.0 |
Recombinant Fusion Proteins/chemistry/genetics/metabolism | 2 | 1.0 |
Male | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Terminal Repeat Sequences/genetics | 2 | 14.0 |
Gene Products, tat/genetics | 2 | 9.0 |
HIV Long Terminal Repeat/*genetics | 3 | 4.0 |
HIV-1/*physiology | 3 | 0.0 |
Protein-Serine-Threonine Kinases/*genetics/metabolism | 2 | 3.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 7 | 0.0 |
Enzyme Inhibitors/*pharmacology | 2 | 0.0 |
Virus Replication/*drug effects | 2 | 1.0 |
Cyclin-Dependent Kinases/*genetics | 2 | 3.0 |
Exons | 2 | 0.0 |
Introns | 2 | 0.0 |
Adenoviridae/genetics | 2 | 0.0 |
3T3 Cells | 5 | 0.0 |
Cell Nucleus/metabolism | 3 | 0.0 |
*Saccharomyces cerevisiae Proteins | 2 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
DNA Polymerase II/metabolism | 2 | 11.0 |
Transcription Factors, TFII/metabolism | 2 | 5.0 |
*Nuclear Proteins | 2 | 0.0 |
Down-Regulation | 2 | 0.0 |
Dimerization | 2 | 0.0 |
*Drosophila Proteins | 2 | 0.0 |
Protein Binding/drug effects | 2 | 0.0 |
Species Specificity | 2 | 0.0 |
Chromatography, Gel | 2 | 0.0 |
Cyclin-Dependent Kinases/metabolism/*physiology | 2 | 22.0 |
Cyclins/metabolism/*physiology | 2 | 20.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Kinetics | 4 | 0.0 |
Two-Hybrid System Techniques | 4 | 0.0 |
Gene Products, tat/*genetics | 4 | 10.0 |
Cell Line, Transformed | 4 | 0.0 |
CHO Cells | 4 | 0.0 |
Hamsters | 4 | 0.0 |
Plasmids/genetics | 2 | 0.0 |
Transcription, Genetic/drug effects/*genetics | 2 | 20.0 |
Tumor Cells, Cultured | 4 | 0.0 |
Rodentia | 2 | 2.0 |
Genes, Reporter/genetics | 2 | 0.0 |
*Cyclin-Dependent Kinases | 2 | 1.0 |
Structure-Activity Relationship | 2 | 0.0 |
Recombinant Proteins/genetics/metabolism | 3 | 0.0 |
RNA Processing, Post-Transcriptional | 2 | 1.0 |
RNA, Messenger/genetics/metabolism | 3 | 0.0 |
Virus Replication | 3 | 0.0 |
RNA, Viral/chemistry/metabolism | 2 | 50.0 |
*HIV-1 | 2 | 0.0 |
Gene Products, tat/genetics/metabolism | 3 | 20.0 |
RNA Interference | 2 | 0.0 |
Drug Synergism | 2 | 0.0 |
CDK9 Protein Kinase/antagonists & inhibitors/*metabolism | 2 | 66.0 |
HIV-1/genetics/*metabolism | 2 | 2.0 |
